Best treatments for neurologic gait disorders
2 products may treat neurologic gait disorders, spanning FDA drug classes such as potassium channel blocker. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.
Quick answer: Of the 2 drugs we list for neurologic gait disorders, all are available as lower-cost generics, spanning classes such as potassium channel blocker. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for neurologic gait disorders — so confirm the right choice with your prescriber.
| # | Drug | Rating | Type | Form | Class | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|---|
| 1 | Not yet rated | Prescription | Tablet | Potassium Channel Blocker | Generic | $12 | View → | |
| 2 | Not yet rated | Prescription | Tablet | Potassium Channel Blocker | Generic | $12 | View → |
Narrow by drug class
Explore the class hubs: potassium channel blocker
Full ranking · 2 treatments
ampyra
PrescriptionFDA-sourced
Ampyra (Dalfampridine) is a potassium channel blocker used to treat Multiple Sclerosis, Neurologic Gait Disorders.
Pharmacy pays
~$11.78 /30
dalfampridine
PrescriptionFDA-sourced
Dalfampridine is a potassium channel blocker used to treat Multiple Sclerosis, Neurologic Gait Disorders.
Pharmacy pays
~$11.78 /30
Frequently asked
- What treats neurologic gait disorders?
- Our catalog lists 2 products that may treat neurologic gait disorders, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists.
- What is the best-rated treatment for neurologic gait disorders?
- Ratings appear as FDA recall-safety data accumulates for the products that may treat neurologic gait disorders.
- How are these treatments ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
- What types of drugs treat neurologic gait disorders?
- Treatments for neurologic gait disorders span FDA drug classes including potassium channel blocker. Compare every option side by side, ranked by independent rating, above.
Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.